FDA Withdraws Approval Of Avastin For Use In Treating Metastatic Breast Cancer
The U.S. Food and Drug Administration (FDA) announced on November 18, 2011 that it was revoking its approval of Avastin (bevacizumab) for use in treating breast cancer (specifically, the use of Avastin in combination with the cancer drug paclitaxel for breast cancer patients suffering from a form of[...]